Recruiting
Phase 2

Checkpoint Inhibition

Sponsor:

Allison O'Neill, MD

Code:

NCT04134559

Conditions

Hepatocellular Carcinoma, Childhood

Fibrolamellar Carcinoma

Liver Cancer

Liver Cancer, Pediatric

Eligibility Criteria

Sex: All

Age: 0 - 30

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-17. This information was provided to ClinicalTrials.gov by Allison O'Neill, MD on 2025-01-28.